DK167138B1 - Farmaceutiske praeparater indeholdende ergotalkaloider - Google Patents

Farmaceutiske praeparater indeholdende ergotalkaloider Download PDF

Info

Publication number
DK167138B1
DK167138B1 DK052086A DK52086A DK167138B1 DK 167138 B1 DK167138 B1 DK 167138B1 DK 052086 A DK052086 A DK 052086A DK 52086 A DK52086 A DK 52086A DK 167138 B1 DK167138 B1 DK 167138B1
Authority
DK
Denmark
Prior art keywords
composition according
dihydro
fat
dihydroergotamine
swelling substance
Prior art date
Application number
DK052086A
Other languages
Danish (da)
English (en)
Other versions
DK52086A (da
DK52086D0 (da
Inventor
Othmar Zueger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858502889A external-priority patent/GB8502889D0/en
Priority claimed from GB858517604A external-priority patent/GB8517604D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK52086D0 publication Critical patent/DK52086D0/da
Publication of DK52086A publication Critical patent/DK52086A/da
Application granted granted Critical
Publication of DK167138B1 publication Critical patent/DK167138B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK052086A 1985-02-05 1986-02-03 Farmaceutiske praeparater indeholdende ergotalkaloider DK167138B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8502889 1985-02-05
GB858502889A GB8502889D0 (en) 1985-02-05 1985-02-05 Co-dergocrine compositions
GB858517604A GB8517604D0 (en) 1985-07-12 1985-07-12 Dihydroergotamine compositions
GB8517604 1985-07-12

Publications (3)

Publication Number Publication Date
DK52086D0 DK52086D0 (da) 1986-02-03
DK52086A DK52086A (da) 1986-08-06
DK167138B1 true DK167138B1 (da) 1993-09-06

Family

ID=26288767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK052086A DK167138B1 (da) 1985-02-05 1986-02-03 Farmaceutiske praeparater indeholdende ergotalkaloider

Country Status (24)

Country Link
JP (1) JPS61183225A (it)
KR (1) KR920010388B1 (it)
AU (1) AU597570B2 (it)
BE (1) BE904152A (it)
CA (1) CA1263087A (it)
CH (1) CH667592A5 (it)
CY (1) CY1604A (it)
DE (1) DE3602577A1 (it)
DK (1) DK167138B1 (it)
ES (1) ES8800040A1 (it)
FR (1) FR2576787B1 (it)
GB (1) GB2170407B (it)
GR (1) GR860310B (it)
HK (1) HK57191A (it)
HU (1) HU195729B (it)
IE (1) IE59293B1 (it)
IT (1) IT1191255B (it)
LU (1) LU86289A1 (it)
NL (1) NL8600161A (it)
NZ (1) NZ215020A (it)
PH (1) PH23384A (it)
PT (1) PT81954B (it)
SE (1) SE8600496L (it)
SG (1) SG56191G (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
YU47044B (sh) * 1987-03-11 1994-12-28 LEK TOVARNA FARMACEVTSKIH IN KEMIČNIH IZDELKOV n.sol.o. Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
CA2393344C (en) * 1999-12-03 2009-09-01 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
NZ504526A (en) * 2000-05-12 2003-05-30 Meracol Corp Ltd Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
DE60132444T2 (de) 2000-05-12 2009-01-22 Meracol Corp. Ltd., Takapuna Behandlung von reizkolon-syndrom oder -krankheit
ES2298237T3 (es) * 2000-05-12 2008-05-16 Meracol Corporation Limited Cetil miristato y cetil palmitato para el tratamiento del eczema y/o de la soriasis.
US20030153620A1 (en) 2000-05-12 2003-08-14 Meakin Timothy David Treating eczema and/or psoriasis
WO2003026640A1 (en) * 2001-09-28 2003-04-03 Meracol Corporation Limited Treating food allergies and/or food intolerances
CN111297815B (zh) * 2020-04-29 2022-04-15 宝利化（南京）制药有限公司 一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
DE3124983A1 (de) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch Arzneiformen zur oralen verabreichung
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) * 1982-02-12 1983-08-25 Sandoz-Patent-GmbH, 7850 Lörrach Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
GB8413795D0 (en) * 1984-05-30 1984-07-04 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
HUT41984A (en) 1987-06-29
LU86289A1 (fr) 1986-09-02
IE59293B1 (en) 1994-02-09
CH667592A5 (de) 1988-10-31
IT1191255B (it) 1988-02-24
PT81954B (pt) 1988-07-01
BE904152A (fr) 1986-08-04
SG56191G (en) 1991-08-23
FR2576787B1 (fr) 1990-01-12
GR860310B (en) 1986-05-27
HK57191A (en) 1991-08-02
GB2170407A (en) 1986-08-06
CY1604A (en) 1992-04-03
GB2170407B (en) 1988-10-26
KR860006265A (ko) 1986-09-09
NZ215020A (en) 1989-07-27
JPS61183225A (ja) 1986-08-15
IT8647620A0 (it) 1986-02-05
IE860291L (en) 1986-08-05
KR920010388B1 (ko) 1992-11-27
DE3602577A1 (de) 1986-08-28
AU5294286A (en) 1986-08-14
CA1263087A (en) 1989-11-21
HU195729B (en) 1988-07-28
SE8600496L (sv) 1986-08-06
DK52086A (da) 1986-08-06
DK52086D0 (da) 1986-02-03
NL8600161A (nl) 1986-09-01
PT81954A (en) 1986-03-01
ES8800040A1 (es) 1987-10-16
ES551635A0 (es) 1987-10-16
AU597570B2 (en) 1990-06-07
GB8602602D0 (en) 1986-03-12
FR2576787A1 (fr) 1986-08-08
PH23384A (en) 1989-07-26
SE8600496D0 (sv) 1986-02-04

Similar Documents

Publication Publication Date Title
AU2002217464B2 (en) Medicinal compositions containing aspirin
DK158540B (da) Orale, ikke-retarderede dipyridamolformer og fremgangsmaade til deres fremstilling
UA76417C2 (en) Pharmaceutical composition comprising immediate release phase and sustained release phase of paracetamol
DK167138B1 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
AU2014299447B2 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
CA1157379A (en) Method of preparation of pharmaceutical composition for treating peripheral orthostatic hypotention
GB2154874A (en) Bromocriptine compositions
IL106743A (en) Tablets with enhanced bioavailability of claudonic acid
JPH1192369A (ja) 医薬品調製物、その製造方法及びシランセトロンの安定化のための酸性添加剤の使用
US5069911A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
JP2665357B2 (ja) 心不全治療用医薬組成物
DK175016B1 (da) Bromcryptinpræparater
US20060122275A1 (en) Agentfor reducing side effects of diclofenac
DK170016B1 (da) Præparat med kontrolleret afgivelse af det aktive stof
JPH0466846B2 (it)
EP0310259B1 (en) Eperisone as a hypotensive agent
WO2011126327A2 (en) Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
JP2002518330A (ja) 処置方法
IE43955B1 (en) Pharmaceutical composition and dosage units thereof
JPH047323B2 (it)
JPS6231682B2 (it)

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed